CRYO CELL INTERNATIONAL INC

CCEL · NYSE · SIC 8090: Services-Misc Health & Allied Services, NEC
306
SEC Filings

Business Summary

Cryo-Cell International, Inc. is a cord blood and cord tissue banking company that collects, processes, and stores umbilical cord blood and cord tissue stem cells for potential future medical use. The company also pursues product diversification through biopharmaceutical manufacturing and operating clinics, holds an IP portfolio including umbilical cord blood and cord tissue license agreements, and engages in collaborative research partnerships related to stem cell therapies.

Next Earnings

Q2 FY2026 — expected 2026-09-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCCELdiscussed_in_filing Healthcare & Bio
topic_mentionCCELdiscussed_in_filing Healthcare & Bio
topic_mentionCCELdiscussed_in_filing Healthcare & Bio
topic_mentionCCELdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-272025-11-300001193125-26-083096EDGAR64K words
2025-02-282024-11-300000950170-25-030138EDGAR—
2024-02-282023-11-300000950170-24-022275EDGAR—
2023-02-282022-11-300000950170-23-005220EDGAR—
2022-02-222021-11-300000950170-22-001637EDGAR—
2021-03-012020-11-300001564590-21-009945EDGAR—
2020-02-282019-11-300001193125-20-056695EDGAR—
2019-02-282018-11-300001193125-19-057945EDGAR—
2018-02-282017-11-300001193125-18-064199EDGAR—
2017-02-282016-11-300001193125-17-062739EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-152025-08-310001193125-25-240385EDGAR41K words
2025-07-152025-05-310000950170-25-095916EDGAR—
2025-04-142025-02-280000950170-25-053767EDGAR—
2024-10-152024-08-310000950170-24-114762EDGAR—
2024-07-152024-05-310000950170-24-083637EDGAR—
2024-04-152024-02-290000950170-24-044493EDGAR—
2023-10-122023-08-310000950170-23-053143EDGAR—
2023-07-142023-05-310000950170-23-033057EDGAR—
2023-04-212023-02-280000950170-23-013868EDGAR—
2022-10-182022-08-310000950170-22-019626EDGAR—
2022-07-112022-05-310000950170-22-012605EDGAR—
2022-04-132022-02-280000950170-22-005662EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001193125-26-104392EDGAR1K words
2025-11-120001193125-25-277872EDGAR—
2025-10-230001193125-25-248883EDGAR—
2025-09-100001193125-25-200170EDGAR—
2025-05-220000950170-25-076433EDGAR—
2025-05-080000950170-25-067147EDGAR—
2024-10-310000950170-24-119642EDGAR—
2024-10-300000950170-24-118607EDGAR—
2024-10-170000950170-24-115106EDGAR—
2024-09-170000950170-24-107340EDGAR—

306 total filings indexed. 274 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

IMTH — AnTix Holdings, Inc. BRTX — BioRestorative Therapies, Inc. DVA — DAVITA INC. MGRX — MANGOCEUTICALS, INC. MRAI — Marpai, Inc. OAKU — Oak Woods Acquisition Corp PFHO — PACIFIC HEALTH CARE ORGANIZATION INC PARK — Park Dental Partners, Inc.

Tags

cord-blood-and-cord-tissue-banking stem-cell-therapies biopharmaceutical-manufacturing healthcare-clinics

Company Identity

CIK0000862692
TickerCCEL
ExchangeNYSE
SIC8090: Services-Misc Health & Allied Services, NEC
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c77ee8822929fa4b7578e503b5abbc8f0918ffb924d2108f63ade946fb907c3b
parent: b1bfccebbf2e5e78d4818849ef48001392b0219cb45b7e2646a2fc07b9b3aa92
content hash: 4645f93dcf4281c777f42c043c327cd44acd074161b0cdb728d00192cd6eff5c
signed: 2026-04-13T04:44:14.017Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf